DGFT amends the Export policy of Injection Remdesivir and Remdesivir API

Jun 15, 2021 | by Avantis RegTech Legal Research Team

A |  A
Loading audio.....

EHS Compliance

The Directorate General of Foreign Trade (DGFT) on June 14, 2021 has issued the amendment in Export policy of Injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) as issued under vide notification no- 01/2015-20, dated April 11, 2021. 

S. No.

ITC HS Codes

Description

Present Policy

Revised Policy

207AA

Ex 293499

Ex 300490

Injection Remdesivir and Remdesivir (API)

Prohibited

Restricted

Further, the export of Remdesivir Injections/API against the Advance Authorizations issued under Chapter 4 of FTP/HBP shall not require a separate export authorization or permission. 

[Notification No- 08/2015-2020]

 

 

 

 

 

 


Bookmark

Related Updates



Alternate Text

Get updates on the go on RuleZbook Mobile App.